정신분열병 환자의 S100B단백 혈청농도에 관한 연구 = Serum S100B Protein in Medication-Free Schizophrenic Patients

다국어 초록 (Multilingual Abstract)

Objectives:Previous studies have suggested that S100B protein play an important role in the pathogenesis and progress of schizophrenia. In the present study, we evaluate the serum levels of S100B in the patients with schizophrenia, and compare them with those of healthy controls. Method:The serum S100B levels were measured by lectrochemiluminescence immunoassay in 21 schizophrenic patients (8 males, 13 females) and 27 normal controls(11 males, 16 females). The Positive and Negative Syndrome Scale(PANSS) was used to evaluate the symptoms of the patients with schizophrenia, and the correlation between PANSS subscale scores and serum S100B levels was examined. Results:No significant difference was found between the serum S100B levels of the schizophrenic patients($0.074{\pm}0.039$ng/ml) and those of the normal controls($0.072{\pm}0.030$ng/ml)(p=0.925). Correlationships between the high serum S100B level with high negative symptom scores(p=0.065) or with the low positive symptom scores(p=0.080) did not exist. Conclusion:The relation between serum S100B level and schizophrenia was not found in the present study. However, to confirm this result, further studies, such as measurement of S100 protein level in CSF, postmortem study, long-term follow-up study, and studies with other neurotrophic proteins are needed.

참고문헌 (Reference)

1 Tateishi N, "[S100B: astrocyte specific protein]" 26 (26): 11-6, 2006

2 Ingebrigtsen T, "Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome." 45 : 468-75, 1999

3 Kay SR, "The positive and negative syndrome scale for schizophrenia" 13 : 261-276, 1987

4 Korfias S, "Slight and short-lasting increase of serum S-100B protein in extra-cranial trauma." 20 (20): 867-872, 2006

5 Raedler TJ, "Shizophrenia as a developmental disorder of the cerebral cortex." 82 : 251-70, 1998

6 Ingebrigtsen T, "Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury." 85 : 945948-, 1996

7 Rothermundt M, "S100B serum levels and long term improvement of negative symptoms in patients with schizophrenia." 29 (29): 1004-1011, 2004

8 Bilder RM, "Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia 서진의학연구소Incheon Chamsarang Hospital" 중앙대학교 병원 정신과학 교실 1-13, 1990apr

9 Ling SH, "Plasma S-100B protein in Chinese patients with schizophrenia: comparison with healthy controls and effect of antipsychotics treatment." 41 (41): 36-42, 2007

10 Donato R, "Perspectives in S-100 protein biology" 12 : 1991

11 Lieberman JA, "Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia." 60 : S9-0S12, 1999

12 Sarandol A, "Oxidative-antioxidative systems and their relation with serum S100B levels in patients with schizophrenia Effects of short term antipsychotic treatment"

13 Tamminga CA, "Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome" 49 : 1992

14 Hyde TM, "Kleinman JE Is there cognitive decline in schizophrenia" 494-500, 1994apr

15 Aylward E, "Intelligence in schizophrenia meta-analysis of the research" 430-59, 1984

16 McAllister CG, "Increases in CSF levels of interleukin-2 in schizophrenia: Effects of recurrence of psychosis and medication status." 152 : 12911297-, 1995

17 Schmitt A, "Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms." 80 (80): 305-313, 2005

18 Stiner J, "Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neuron-specific enol;ase from glia or neurons." 77 (77): 1284-1287, 2006

19 Ehrenreich H, "Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin." 12 (12): 206-220, 2007

20 Lim KO, "Gray matter deficits in young onset schizophrenia are independent of age of onset." 40 : 4-13, 1996

21 Rothermundt M, "Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol." 31 (31): 361-364, 2007

22 Goncalves DS, "Extracellular S100B Protein Modulates ERK in Astrocyte Cultures." 11 : 807-809, 2000

23 Wiesmann M, "Elevated plasma levels of S-100b protein in schizophrenic patients." 45 (45): 1508-1511, 1999

24 Gattaz WF, "Decreased S100-beta protein in schizophrenia: preliminary evidence." 43 (43): 91-95, 2003

25 Hoff AL, "Cross-sectional and longitudinal neuropsychological test findings in first episode schizophrenic patients" 1991oct197-8

26 Lamers KJB, "Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders." 92 : 247251-, 1995

27 Petzold A, "Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease." 336 (336): 167-170, 2003

28 Foster R, "Calprotectin in microglia from frontal cortex is up-regulated in schizophrenia: evidence for an inflammatory process?" 24 (24): 3561-3566, 2006

29 Ganguli R, "Autoimmunity in schizophrenia" 25 : 1993

30 Missler U, "Acute exacerbation of multiple sclerosis increases plasma levels of S-100 protein." 96 : 142144-, 1997a